Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Subcutaneous Methotrexate in Moderate to Severe Psoriasis
NCT03408756Phase 4Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Apr 2018
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of methotrexate in Psoriasis vulgaris (PV), sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT03408756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408756.